Suggestions
Sriram Ganapathy
Cancer Biologist and Immunologist passionate about research, teaching, and mentoring
Sriram Ganapathy is a scientist specializing in immunology, currently working at Flagship Labs 65 Inc. in Cambridge, Massachusetts. His professional focus is on leveraging immuno-oncology to develop innovative cancer therapies, particularly through the integration of chemotherapy and immune stimulants to enhance anti-cancer responses. He has been involved in developing cancer vaccines aimed at effective cancer management.1
Educational Background
-
Bachelor of Engineering (BEng), Biotechnology
PES Institute of Technology (2003 - 2007) -
Doctor of Philosophy (PhD), Biochemistry and Cancer Biology
Rutgers University (2008 - 2014)
Professional Experience
-
Scientist - Immunology
Flagship Labs 65 Inc. (October 2020 - July 2021) -
Senior Scientist, Immuno-Oncology
EMD Serono, Inc. (August 2021 - March 2024) -
Postdoctoral Researcher
Massachusetts Institute of Technology (MIT) (March 2015 - October 2020) -
Postdoctoral Fellow
Rutgers University (June 2014 - February 2015)
Research Interests
Ganapathy's research interests include cancer biology and immunology, with a particular emphasis on the development of therapies that combine immune modulation with traditional cancer treatments. His work aims to create lasting anti-cancer effects through innovative therapeutic strategies.1
